Kwang Dong Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Kwang Dong Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Kwang Dong Pharmaceutical has seen a decline in its Price, from ₩8635.19 to ₩0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Kwang Dong Pharmaceutical will be 100.00%.
Kwang Dong Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Revenue for Kwang Dong Pharmaceutical has grown by 15.10%, going from ₩1.24T to ₩1.43T. According to the 0 analysts polled, in the next year, Kwang Dong Pharmaceutical's Revenue will fall by 6.70%, reaching ₩1.34T. By 2030, professionals believe that Kwang Dong Pharmaceutical's Revenue will have decreased by 6.46%, falling to ₩1.34T.
.jpg)
Kwang Dong Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Kwang Dong Pharmaceutical's Dividend per Share has decreased by 0.00%, from ₩100.00 to ₩100.00. For the next year, 0 analysts project Kwang Dong Pharmaceutical's Dividend per Share to drop by 0.00%, reaching ₩100.00. By 2030, professionals believe that Kwang Dong Pharmaceutical's Dividend per Share will decrease by 0.00%, reaching ₩100.00 – a concerning trend for the company.
Kwang Dong Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
Kwang Dong Pharmaceutical's EBITDA has decreased In the last two years, from ₩66.30B to ₩52.26B – a 21.17% drop. For next year, the 0 analysts predict EBITDA of ₩58.92B, which would mean an increase of 12.75%. Over the next eight years, the pros' prediction is EBITDAof ₩59.38B, which would mean a eight-year growth forecast of 13.63%.
Kwang Dong Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Kwang Dong Pharmaceutical's EBIT has seen a drop from ₩46.59B to ₩38.24B – a 17.91% decrease. In the next year, analysts expect EBIT to reach ₩43.18B – an increase of 12.89%. For the next eight years, the forecast is for EBIT to grow by 13.87%.
Kwang Dong Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Kwang Dong Pharmaceutical has seen a decline in its EPS, from ₩719.00 to ₩0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Kwang Dong Pharmaceutical will be 100.00%.
Site Navigation
.jpg)